Professor Garth Cooper’s contribution to science recognised by the University of Oxford

07 September 2017
Professor Garth Cooper, School of Biological Sciences, admitted to the Degree of Doctor of Science (DSc) by the University of Oxford (July 2017)
Professor Garth Copper

Professor Garth Cooper from the School of Biological Sciences was admitted to the Degree of Doctor of Science (DSc) by the University of Oxford at the Degree Ceremony, held at the Sheldonian Theatre in late July this year.

The University of Oxford confers just two or three of these higher degrees in medical sciences each year, and his DSc acknowledges Professor Cooper’s lifetime of achievement in biomedicine.

As a DPhil graduate from the University of Oxford, Professor Cooper was able to supplicate for a DSc, for which the examination process is rigorous.

He had to compile a collection of his top twenty publications, along with an outline of his research achievements, in addition to two full sets of his publications bound in two hardcover volumes. These were submitted to the registrar for examination – and he was pleased to hear the examination board had awarded the DSc on the merit of his career achievements.

Professor Cooper is named as inventor of more than 40 issued US and European patents. He discovered the hormone amylin while pursuing doctoral studies at Oxford University, and developed amylin-replacement therapy for diabetes using an engineered homologue.

His research has led to major advances in the understanding of disease mechanisms in diabetes and related syndromes and, based on these mechanisms, to the discovery of several new experimental therapies for these conditions.

Currently, Professor Cooper is investigating new therapies to suppress diabetes, a programme that has received continuous funding from FRST/MSI/MBIE since 1999.